Latest News
Latest News
Peanut allergy pill gets thumbs-up from FDA advisory panel
The approval of Palforzia is on condition that a black-box warning and medication guide are included in the packaging.
FDA/CDC
FDA issues warning for CDK 4/6 inhibitors
In a review of trials and postmarket safety databases, the FDA found there were reports of serious cases of pneumonitis, including fatalities,...
Conference Coverage
Most patients with RIS develop MS within 10 years
STOCKHOLM – The conversion rate jumps to 87% in the presence of four risk factors at baseline.
Conference Coverage
BP load predicts cardiovascular damage in children
NEW ORLEANS – The amount of time spent above the 95th blood pressure percentile is an emerging metric of pediatric hypertension control.
News
Benralizumab trials cast doubt on eosinophil depletion’s role in COPD treatment
The anti–interleukin-5 receptor antibody did not reduce COPD exacerbations in phase 3 trials.
Conference Coverage
Continuous treatment reduces risk of confirmed disability progression in MS
STOCKHOLM – The risk of confirmed disability progression appears to decrease with increasing length of continuous...
News
Drug doses for heart failure could possibly be halved for women
News
Can a novel steroidal anti-inflammatory drug benefit patients with Duchenne muscular dystrophy?
Vamorolone may reduce “safety concerns typically seen with traditional glucocorticoids,” researchers said.
News
Insurers to pay record number of rebates to patients
Insurers will pay $1.3 billion in medical loss ratio rebates to patients in 2019 based on collected premiums.
News
New genotype of S. pyrogenes found in rise of scarlet fever in U.K.